Investment portfolio.
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
VESALIUS BIOCAPITAL I
Détention du capital6.67 %
Venture capital fund that invests in life science companies creating innovative cutting-edge technologies.
VESALIUS BIOCAPITAL III
Détention du capital8.92 %
Vesalius Biocapital III was established as a European venture capital fund in the life sciences field. The fund has set itself the goal of building up a balanced portfolio consisting of between 10 and 12 companies that develop new medicines, diagnostics, medical devices and applications for digital healthcare.
VIVES II
Détention du capital11.68 %
Vives II is a multi-sectorial UCL associated investment fund for investment in new high-tech companies which, in particular, produce innovative work in the field of ecology.
VIVES INTER-UNIVERSITY FUND
Détention du capital20 %
Launched in the summer of 2020, the Vives Inter-University Fund (Vives III) is a multi-sector technology fund that invests in projects with a positive impact on society. The fund invests in spin-offs from UCLouvain [Catholic University of Louvain] or its universities as well as in start-ups.
<div id="ConnectiveDocSignExtentionInstalled" data-extension-version="1.0.4"></div>
VOLTA VENTURES
Détention du capital8.63 %
<p class="p1">Following the example of its predecessor Volta Ventures I, which was launched in 2014, this fund invests in software and internet companies in the Benelux. The Volta Ventures team aims to acquire stakes in around twenty companies over the next five years. It will focus on innovative start-ups with strong and balanced teams, but also on a unique market position and a scalable business model.</p>
<div id="ConnectiveDocSignExtentionInstalled" data-extension-version="1.0.4"></div>
WELLINGTON PARTNER LIFE SCIENCES V GmbH (EIF)
Détention du capital1.43 %
Wellington Partners Technology is a leading European venture capital firm specialising in investments in early- and growth-stage technology and life science companies.
<div id="ConnectiveDocSignExtentionInstalled" data-extension-version="1.0.4"></div>
WHITE FUND (Medtech)
Détention du capital15.08 %
White fund was created in October 2019 and aspires to become the new reference investment fund in Belgium for early stage medtech companies.
ZEPHYR-FIN
Détention du capital100 %
This company acquires and manages securities issued by airlines or companies linked to that industry.